Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a firmly bearish stance to a mildly bearish trend. Despite this slight improvement, the stock remains under pressure with a strong sell rating and a market cap classified as small-cap. This article analyses the recent technical indicators, price movements, and relative performance against the broader market to provide a comprehensive view for investors.

Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 March 2026, providing investors with the latest perspective on the company’s position.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Niva Bupa Health Insurance Company Ltd has declined to a fresh 52-week low of Rs 67.97, reflecting ongoing pressures within the insurance sector and broader market weakness. The stock’s recent performance underscores a challenging period marked by subdued quarterly results and a cautious market environment.

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite this slight improvement, key technical indicators continue to signal caution for investors, reflecting ongoing challenges in the insurance sector and broader market pressures.

Niva Bupa Health Insurance Company Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 March 2026, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance. The company’s Mojo Score improved to 31.0, reflecting a nuanced view of its prospects amid a mixed backdrop of valuation, quality, financial trends, and technical signals.

Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with the latest insights into its performance and outlook.

Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 13 February 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Niva Bupa Health Insurance Company Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 January 2026, reflecting deteriorating valuation metrics, flat financial trends, and weak technical signals. The company’s Mojo Score has dropped to 26.0, underscoring heightened risk perceptions amid challenging market conditions and disappointing quarterly results.

Niva Bupa Health Insurance Company Ltd has experienced a marked deterioration in its valuation metrics, shifting from a previously expensive rating to a risky classification. This change, coupled with weak profitability indicators and a challenging peer comparison, raises significant concerns for investors assessing the stock’s price attractiveness amid a volatile insurance sector.

Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 31 January 2026, providing investors with the most up-to-date analysis.

Niva Bupa Health Insurance Company Limited reported a net loss of ₹35.27 crores in Q2 FY26, marking a significant deterioration from the ₹13.02 crore profit posted in the same quarter last year. The quarter-on-quarter performance showed marginal improvement with losses narrowing by 61.43% from Q1 FY26's ₹91.44 crore loss, yet the company remains mired in operational challenges despite posting decent top-line growth. The stock, currently trading at ₹78.00 with a market capitalisation of ₹14,297 crores, has underperformed the broader insurance sector by 24.26 percentage points over the past year.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 31 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 09 January 2026, providing investors with the latest insights into its performance and valuation.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of its performance and outlook.

Niva Bupa Health has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. The insurance company’s recent assessment highlights a complex interplay of valuation concerns, subdued financial performance, and technical indicators that have influenced investor sentiment.